EGFR and cancer: In summary, the above studies indicate that after the activation of EGFR signaling in cancer cells, the recruitment of immune active cells is mainly reduced, and the recruitment of immune suppressive cells is increased by releasing cytokines to form an immune suppressive microenvironment, thereby promoting tumor immune escape.